Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Initial levothyroxine dose comparison in children with congenital hypothyroidism
2010-023481-41Phase 4Active
- Sponsor
- University of Naples Federico II
- Start
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of levothyroxine sodium in congenital hypothyroidism (CH) (2 arms), sponsored by University of Naples Federico II. Primary endpoints: Best initial thyroid hormone replacement dose for long-term developmental outcome and Long-term neurodevelopmental and auxological outcomes. Started Feb 2011; status: active.
02
Drugs
levothyroxine sodium
03
Conditions
congenital hypothyroidism (CH)
Beyond the preview
Go deeper on 2010-023481-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023481-41.